Literature DB >> 33409677

Comparison between two multimodal imaging platforms: Nidek Mirante and Heidelberg Spectralis.

Kimberly Spooner1, Long Phan1,2, Mariano Cozzi3, Thomas Hong1, Giovanni Staurenghi3, Eugenia Chu1, Andrew A Chang4,5.   

Abstract

PURPOSE: To investigate the reliability and comparability of retinal measurements obtained with spectral-domain optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), confocal scanning laser ophthalmoscopy (cSLO) colour images, and fundus autofluorescence (FAF) between two multimodal imaging platforms in eyes with macular pathology and normal, healthy volunteers.
METHODS: This cross-sectional, multi-centre, instrument validation study recruited 94 consecutive subjects. All participants underwent a dilated examination and were scanned consecutively on the Heidelberg Spectralis (Heidelberg Engineering, Heidelberg, Germany) and Nidek Mirante (Nidek Co. Ltd., Gamagori, Japan) devices. Agreement between device images were evaluated from measures of the central retinal thickness (CRT), presence of segmentation and fixation imaging artefacts (IA), foveal avascular zone (FAZ) measurements; as well as sensitivity and specificity values from the detection of atrophy on fundus autofluorescence (FAF), drusen, subretinal drusenoid deposits, geographic atrophy, epiretinal membrane, fibrosis and haemorrhage on multicolour imaging, and agreement between devices and groups.
RESULTS: Compared with reference clinical examination, sensitivity values for the identification of retinal features using sole device images ranged from 100% for epiretinal membranes to 66.7% for subretinal drusenoid deposits (SSD). Mean absolute difference for CRT between OCT devices was 3.78 μm (95% confidence interval [CI]: - 21.39 to 28.95, P = 0.809). Differences in the superficial and deep capillary plexus FAZ area on OCTA between devices were not statistically significant (P = 0.881 and P = 0.595, respectively). IAs were significantly increased in the presence of macular pathology.
CONCLUSION: Comparison of retinal measurements between the OCT devices did not differ significantly. Common ultrastructural biomarkers of multiple macular pathologies were identified with high sensitivities and specificities, with good agreement between graders, indicating that they can be identified with comparable confidence in retinal imaging between the two devices.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Fundus autofluorescence (FAF); Mirante; Multicolour (MC); Optical coherence tomography (OCT); Spectralis

Year:  2021        PMID: 33409677     DOI: 10.1007/s00417-020-05050-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

Review 1.  The scanning laser ophthalmoscope--a review of its role in bioscience and medicine.

Authors:  P F Sharp; A Manivannan; H Xu; J V Forrester
Journal:  Phys Med Biol       Date:  2004-04-07       Impact factor: 3.609

2.  RETOUCH: The Retinal OCT Fluid Detection and Segmentation Benchmark and Challenge.

Authors:  Hrvoje Bogunovic; Freerk Venhuizen; Sophie Klimscha; Stefanos Apostolopoulos; Alireza Bab-Hadiashar; Ulas Bagci; Mirza Faisal Beg; Loza Bekalo; Qiang Chen; Carlos Ciller; Karthik Gopinath; Amirali K Gostar; Kiwan Jeon; Zexuan Ji; Sung Ho Kang; Dara D Koozekanani; Donghuan Lu; Dustin Morley; Keshab K Parhi; Hyoung Suk Park; Abdolreza Rashno; Marinko Sarunic; Saad Shaikh; Jayanthi Sivaswamy; Ruwan Tennakoon; Shivin Yadav; Sandro De Zanet; Sebastian M Waldstein; Bianca S Gerendas; Caroline Klaver; Clara I Sanchez; Ursula Schmidt-Erfurth
Journal:  IEEE Trans Med Imaging       Date:  2019-02-26       Impact factor: 10.048

3.  Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography.

Authors:  Richard F Spaide; James M Klancnik; Michael J Cooney
Journal:  JAMA Ophthalmol       Date:  2015-01       Impact factor: 7.389

4.  Reproducibility of Vessel Density, Fractal Dimension, and Foveal Avascular Zone Using 7 Different Optical Coherence Tomography Angiography Devices.

Authors:  Federico Corvi; Marco Pellegrini; Stefano Erba; Mariano Cozzi; Giovanni Staurenghi; Andrea Giani
Journal:  Am J Ophthalmol       Date:  2017-11-21       Impact factor: 5.258

5.  Macular Perfusion Parameters in Different Angiocube Sizes: Does The Size Matter in Quantitative Optical Coherence Tomography Angiography?

Authors:  Alessandro Rabiolo; Francesco Gelormini; Alessandro Marchese; Maria Vittoria Cicinelli; Giacinto Triolo; Riccardo Sacconi; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

6.  Prevalences of segmentation errors and motion artifacts in OCT-angiography differ among retinal diseases.

Authors:  J L Lauermann; A K Woetzel; M Treder; M Alnawaiseh; C R Clemens; N Eter; Florian Alten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-07       Impact factor: 3.117

7.  Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography.

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

8.  Reproducibility of spectral-domain optical coherence tomography measurements in adult and pediatric glaucoma.

Authors:  Fatema F Ghasia; Mays El-Dairi; Sharon F Freedman; Anand Rajani; Sanjay Asrani
Journal:  J Glaucoma       Date:  2015-01       Impact factor: 2.503

9.  Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements.

Authors:  Mehran Taban; Sumit Sharma; Dawn R Williams; Nadia Waheed; Peter K Kaiser
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

Review 10.  Optical coherence tomography: A guide to interpretation of common macular diseases.

Authors:  Muna Bhende; Sharan Shetty; Mohana Kuppuswamy Parthasarathy; S Ramya
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.